Lupin Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Lupin Pharmaceuticals

Access the complete profile.

Lupin Pharmaceuticals Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	4242 Drugs & Druggists' Sundries Merchant Wholesalers
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	111 S Calvert St Fl 21 Baltimore, MD 21202

Note: Revenues for privately held companies are statistical evaluations.


Lupin Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Lupin Pharmaceuticals's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Lupin Pharmaceuticals is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry, NAICS Code 4242.

Lupin Pharmaceuticals Annual Revenue and Growth Rate

Lupin Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Lupin Pharmaceuticals's revenues are gauged from an analysis of company filings.

Lupin Pharmaceuticals's Income Statement (based on Industry Averages)

Lupin Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Lupin Pharmaceuticals is developing and marketing. Lupin Pharmaceuticals doesn't have any recent trademark applications, indicating Lupin Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
PULSING BLENDS pharmaceutical powder for prevention and treatment of respiratory diseases and disorders	06/30/2015
FLASH BLENDS pharmaceutical powder for prevention and treatment of respiratory diseases and disorders	06/30/2015

See all trademarks and details in the Full Report.

Market Share of Lupin Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Lupin Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AMERISOURCEBERGEN	Conshohocken, PA	100
MCKESSON	Irving, TX	58
CARDINAL HEALTH 119	Dublin, OH	42
TAKEDA PHARMACEUTICALS AMERICA	Lexington, MA	31
CATALENT PHARMA SOLUTIONS	Somerset, NJ	13
OWENS & MINOR DISTRIBUTION	Mechanicsville, VA	11
J M SMITH	Spartanburg, SC	3
DAIICHI SANKYO	Basking Ridge, NJ	3
HIKMA PHARMACEUTICALS USA	Berkeley Heights, NJ	2

Nearby Competitors

These companies are similar in business line and location to Lupin Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
CARROLL INDEPENDENT FUEL	Baltimore, MD	100
TILLEY CHEMICAL	Middle River, MD	17
L. FISHMAN & SON	Baltimore, MD	11
LUPIN PHARMACEUTICALS	Baltimore, MD	10
BUCK WEAR	Baltimore, MD	3
GEORGE J. FALTER	Baltimore, MD	3
ORIGIN AMERICAS	Baltimore, MD	3
EMD SALES	Baltimore, MD	3
A & L FOODS	Baltimore, MD	2
BACCHUS IMPORTERS	Baltimore, MD	2

Future Competition: Lupin Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Lupin Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)